Rising curiosity in American microdosing caps reflects a transformation in mental health approaches.
What is considered a dose of psilocybin?
A common microdose ranges from 0.1 mg to 0.3 mg of pure psilocybin, well under the full therapeutic dose used in clinical trials.
Medical research on psilocybin
Latest research suggest the potential of psilocybin microdoses in treating depression, with thousands treated with peer reviewed articles on psilocybin psilocybin reporting improved mood.
Legality
Is psilocybin a controlled substance? Legal status is state‑dependent, with Maryland and certain US jurisdictions moving toward medical legalization.
- Potential side effects are generally mild, such as headache.
- Scientific publications highlight variations in potency.
- Global research contribute additional evidence on therapeutic outcomes.
The latest news on psilocybin research emphasize that controlled dosing is receiving increased attention across the US.